THE ANTI-ALLERGIC ACTIVITY OF BUCHANANIA LANZAN SPRENG. LEAVES ON MAST CELL MEDIATED ALLERGIC MODELS
Journal: Indo American Journal of Pharmaceutical Sciences (IAJPS) (Vol.05, No. 02)Publication Date: 2018-02-18
Authors : V. N. Shevale V. M. Chandrashekhar I. S. Muchandi V. G. Saudagar;
Page : 832-838
Keywords : Compound 48/80; Anti-allergic; Mast cells; Buchanania lanzan; Antihistaminic.;
Abstract
Objectives: The purpose of this study was to assess the anti-allergic action of Methanol extract of plant Buchanania lanzan Spreng. leaves on mast cell intermediated allergic models. Materials and methods: The methanol extracts of plant Buchanania lanzan spreng. Leaves protecting effect is checked in pruritus and anaphylaxis models of the acute phase of allergic reactions induced by compound 48/80. The mast cell degranulation and histamine release from blood induced by compound 48/80 is determined. Results: The methanol extract of Buchanania lanzan Spreng. Leaves produced noteworthy inhibition of pruritus and anaphylaxis induced by compound 48/80 and Dose-dependent noteworthy Stabilization of mast cell membrane is also observed in compound 48/80 induced mast cell activation. It is observed that the dose-dependant decrease in the release of histamine. Conclusion: These results show the methanol extract of plant Buchanania lanzan Spreng. Leaves by inhibition of histamine release from mast cells have efficient anti-allergic property. Keywords: Compound 48/80, Anti-allergic, Mast cells, Buchanania lanzan, Antihistaminic.
Other Latest Articles
- ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF METFORMIN AND VOGLIBOSE IN BULK AND FIXED DOSE COMBINATION (TABLETS) BY RP-HPLC
- INDIVIDUAL DIFFERENCES IN THE MENTAL REGION ACCORDING TO MACROANATOMICAL STUDY DATA
- EVALUATING THE CHEMICAL ANALYSIS PROFILE OF SOME LESSER KNOWN EDIBLE FRUITS
- DESIGN AND DEVELOPMENT OF MATRIX TABLET OF LABETALOL HCL BY USING TAMARIND SEED POLYSACCHARIDE AS POLYMER
- IS THE RISK OF CARDIOVASCULAR DISEASE DUE TO HUMAN IMMUNODEFICIENCY VIRUS INFECTION OR ITS THERAPY?
Last modified: 2018-02-20 02:27:31